Page last updated: 2024-10-19

orotic acid and Bright Disease

orotic acid has been researched along with Bright Disease in 1 studies

Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siniachenko, OV1
Diadyk, AI1
Oberemchenko, IaV1
Vasilenko, IV1
Nikolenko, IuI1

Other Studies

1 other study available for orotic acid and Bright Disease

ArticleYear
[Dispensarization of patients with podagra and renal lesions].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:8

    Topics: Adult; Aged; Allopurinol; Ambulatory Care; Cyclophosphamide; Drug Therapy, Combination; Female; Glom

1985